Brain Metastasis Questions & Answers

1. Sacks P, Rahman M. Epidemiology of Brain Metastases. Neurosurg Clin N Am. 2020 Oct. 31 (4):481-488. [QxMD MEDLINE Link].

2. Santarelli JG, Sarkissian V, Hou LC, Veeravagu A, Tse V. Molecular events of brain metastasis. Neurosurg Focus. 2007 Mar 15. 22(3):E1. [QxMD MEDLINE Link].

3. Andrade AC, Ferruzzi DS, Panis C. Brain-metastatic breast cancer: clinical considerations and pharmacological approaches. Anticancer Agents Med Chem. 2016 Apr 4. [QxMD MEDLINE Link].

4. Rusciano D, Burger MM. Mechanisms of Metastases. levine AJ, Schmidek HH (eds). In Molecular Genetics of Nervous System Tumors. New York: John Wiley & Son; 1993.

5. Nolte SM, Venugopal C, McFarlane N, Morozova O, Hallett RM, O'Farrell E. A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer. J Natl Cancer Inst. 2013 Feb 15. [QxMD MEDLINE Link].

6. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 8. 438(7069):820-7. [QxMD MEDLINE Link].

7. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 8. 438(7069):820-7. [QxMD MEDLINE Link]. [Full Text].

8. Johnson JD, Young B. Demographics of brain metastasis. Neurosurg Clin N Am. 1996 Jul. 7 (3):337-44. [QxMD MEDLINE Link].

9. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012 Feb. 14 (1):48-54. [QxMD MEDLINE Link].

10. Nieder C, Mehta MP, Geinitz H, Grosu AL. Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms. Crit Rev Oncol Hematol. 2018 Jun. 126:13-18. [QxMD MEDLINE Link].

11. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997 Mar 1. 37(4):745-51. [QxMD MEDLINE Link].

12. Sheehan J. Radiosurgery for breast cancer. J Neurosurg. 2011 Mar. 114(3):790-1; discussion 791. [QxMD MEDLINE Link].

13. Hanssens P, Karlsson B, Yeo TT, Chou N, Beute G. Detection of brain micrometastases by high-resolution stereotactic magnetic resonance imaging and its impact on the timing of and risk for distant recurrences. J Neurosurg. 2011 Sep. 115(3):499-504. [QxMD MEDLINE Link].

14. Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol. 1994 Mar. 162(3):671-7. [QxMD MEDLINE Link].

15. Shonka N, Venur VA, Ahluwalia MS. Targeted Treatment of Brain Metastases. Curr Neurol Neurosci Rep. 2017 Apr. 17 (4):37. [QxMD MEDLINE Link].

16. Galicich JH, French LA. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat. 1961 Mar. 12:169-74. [QxMD MEDLINE Link].

17. Park SJ, Kim HT, Lee DH, Kim KP, Kim SW, Suh C. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer. 2012 Sep. 77(3):556-60. [QxMD MEDLINE Link].

18. Soffietti R, Trevisan E, Rudà R. Targeted therapy in brain metastasis. Curr Opin Oncol. 2012 Nov. 24(6):679-86. [QxMD MEDLINE Link].

19. Verma J, Jonasch E, Allen P, Tannir N, Mahajan A. Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma. Cancer. 2011 Nov 1. 117(21):4958-65. [QxMD MEDLINE Link].

20. Azim HA, Azim HA Jr. Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions. Future Oncol. 2012 Feb. 8(2):135-44. [QxMD MEDLINE Link].

21. [Guideline] Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol. 2022 Feb 10. 40 (5):492-516. [QxMD MEDLINE Link].

22. Mulcahy N. Spare the Hippocampus in Brain Radiotherapy, Preserve Memory. Available at http://www.medscape.com/viewarticle/811926. Accessed: October 7, 2013.

23. Chitti B, Goyal S, Sherman JH, Caputy A, Sarfaraz M, Cifter G, et al. The role of brachytherapy in the management of brain metastases: a systematic review. J Contemp Brachytherapy. 2020 Feb. 12 (1):67-83. [QxMD MEDLINE Link].

24. Kaye J, Patel NV, Danish SF. Laser interstitial thermal therapy for in-field recurrence of brain metastasis after stereotactic radiosurgery: does treatment with LITT prevent a neurologic death?. Clin Exp Metastasis. 2020 Jun. 37 (3):435-444. [QxMD MEDLINE Link].

25. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 2011. 6:48. [QxMD MEDLINE Link].

26. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg. 1993 Aug. 79(2):210-6. [QxMD MEDLINE Link].

27. Cho KH, Hall WA, Lee AK. Stereotactic radiosurgery for patients with single brain metastasis. J Radiol. 1998. 1:79-85.

28. Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996 Apr 1. 35(1):27-35. [QxMD MEDLINE Link].

29. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011 Jan 10. 29(2):134-41. [QxMD MEDLINE Link]. [Full Text].

30. Lo SS, Sloan AE, Machtay M. Stereotactic radiosurgery for more than four brain metastases. Lancet Oncol. 2014 Apr. 15(4):362-3. [QxMD MEDLINE Link].

31. Pullen LC. Biomarker identifies brain metastases in lung cancer patients. Medscape Medical News. November 20, 2013. [Full Text].

32. Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014 Apr. 15(4):387-95. [QxMD MEDLINE Link].

Victor Tse, MD, PhD Clinical Professor (Affiliated Clinical Educator Line), Department of Neurosurgery and Neurosciences, Stanford University School of Medicine; Neurosurgeon, Kaiser Neuroscience of Northern California

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Jorge C Kattah, MD Head, Associate Program Director, Professor, Department of Neurology, University of Illinois College of Medicine at Peoria

Jorge C Kattah, MD is a member of the following medical societies: American Academy of Neurology, American Neurological Association, New York Academy of Sciences

Disclosure: Nothing to disclose.

Nicholas Lorenzo, MD, CPE, MHCM, FAAPL Co-Founder and Former Chief Publishing Officer, eMedicine and eMedicine Health, Founding Editor-in-Chief, eMedicine Neurology; Founder and Former Chairman and CEO, Pearlsreview; Founder and CEO/CMO, PHLT Consultants; Former Chief Medical Officer, MeMD Inc

Nicholas Lorenzo, MD, CPE, MHCM, FAAPL is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Association for Physician Leadership

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article